Temporal trends and clinical characteristics of drug-coated balloon angioplasty for de dovo coronary lesions: A five-year analysis from the ORPKI Registry
Drug-coated balloons (DCB) have emerged as a compelling stent-free alternative in percutaneous coronary intervention (PCI), combining the mechanical benefits of balloon angioplasty with targeted, localized antiproliferative drug delivery. While established for in-stent restenosis, there is growing clinical intere...